- Home
- MDXG vs PWRL Comparison
MDXG vs PWRL Comparison
Compare MDXG & PWRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDXG | PWRL |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.6M | 658.6M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | MDXG | PWRL |
|---|---|---|
| Price | $4.14 | $11.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 118.1K |
| Earning Date | 04-29-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $418,630,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.02 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.99 | N/A |
| 52 Week Low | $3.03 | $11.00 |
| 52 Week High | $7.97 | $16.31 |
Technical Indicators
Market Signals| Indicator | MDXG | PWRL |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 35.87 |
| Support Level | $4.09 | N/A |
| Resistance Level | $4.45 | $13.39 |
| Average True Range (ATR) | 0.20 | 0.76 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 56.55 | 13.39 |
Price Performance
Historical ComparisonAbout MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About PWRL Powerlaw Corp. Common Stock
Powerlaw Corp is a non-diversified, closed-end management investment company. The Fund's investment objective is long-term capital appreciation. It seeks to achieve its investment objective by investing in the equity and equity-linked securities of a concentrated portfolio of approximately 12 to 15 late-stage technology companies.